Tirzepatide

Tirzepatide is a synthetic peptide analog engineered for advanced metabolic and endocrinology research. It is uniquely characterized as a dual agonist of the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, making it a compound of significant interest in laboratory studies focused on metabolic signaling pathways.

This dual-receptor activity distinguishes tirzepatide from single-pathway peptides and has made it a subject of extensive investigation in research settings exploring energy balance, insulin signaling, glucose metabolism, and appetite regulation mechanisms.